rVA576
AK801
Phase 2 small_molecule completed
Quick answer
rVA576 for Bullous Pemphigoid (BP) is a Phase 2 program (small_molecule) at Akari Therapeutics Plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Akari Therapeutics Plc
- Indication
- Bullous Pemphigoid (BP)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed